High-Throughput Screening for Readthrough Modulators of CFTR PTC Mutations
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-Throughput Screening for Readthrough Modulators of CFTR PTC Mutations
Authors
Keywords
-
Journal
SLAS Technology
Volume 22, Issue 3, Pages 315-324
Publisher
SAGE Publications
Online
2017-05-26
DOI
10.1177/2472630317692561
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
- (2016) Gudio Veit et al. MOLECULAR BIOLOGY OF THE CELL
- Robust Stimulation of W1282X-CFTR Channel Activity by a Combination of Allosteric Modulators
- (2016) Wei Wang et al. PLoS One
- Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression
- (2016) Bijoyita Roy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Some gating potentiators, including VX-770, diminish F508-CFTR functional expression
- (2014) G. Veit et al. Science Translational Medicine
- Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial
- (2014) Eitan Kerem et al. Lancet Respiratory Medicine
- Organizing Principles of Mammalian Nonsense-Mediated mRNA Decay
- (2013) Maximilian Wei-Lin Popp et al. Annual Review of Genetics
- Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
- (2013) Patrick R Sosnay et al. NATURE GENETICS
- A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect
- (2013) Michael P Boyle et al. Lancet Respiratory Medicine
- Suppression of premature termination codons as a therapeutic approach
- (2012) Kim M. Keeling et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Identification of a NBD1-Binding Pharmacological Chaperone that Corrects the Trafficking Defect of F508del-CFTR
- (2011) Heidi M. Sampson et al. CHEMISTRY & BIOLOGY
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
- (2011) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutation
- (2010) Frank J. Accurso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
- (2009) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report
- (2008) Philip M. Farrell et al. JOURNAL OF PEDIATRICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started